A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 2300 participants.

Also called NCT07788989

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07788989
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07788989. Non-randomized; no masking; primary purpose treatment. Start 2027-04-14 (anticipated); primary completion 2029-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter
Acronym
SPECTRA-AF
Intervention (Device)
VARIPULSE Catheter System (PVI)
Intervention (Device)
VARIPULSE Catheter System (PVI and PWI)
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07788989
Content hash
4ea362099ed5bed4b0830e5cdd0034ce17a6f2512794c27b86114273a3f2d7dc